Research suggests that on-site audits are becoming less meaningful because suppliers are less willing to devote time to them.
Michael Pfeiffer, PhD
Advertisement
Michael Pfeiffer, PhD is global quality manager at Boehringer Ingelheim Pharma GmbH&Co. KG, Binger StraÃe 173, 55216Ingelheim a. Rh., Germany; Tel.: +49 (0) 6132-777013;[email protected].
Articles by Michael Pfeiffer, PhD
Pharmaceutical Technology Europe
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
Advertisement
Latest Updated Articles
Trends in On-Site Supplier AuditsAugust 1st 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5